Skip to main content
. 2021 Mar 30;14(1):81–86. doi: 10.4103/jhrs.jhrs_239_20

Figure 2.

Figure 2

The majority (60.70%) of the respondent discuss fertility issue with their cancer patients, however only a few of them (39.30%) consult with and refer the patients to the fertility experts. Written information regarding gonadotoxicity of the chemotherapeutic agents was rarely (32.10%) given to the patients. (ANOVA, p< 0.05)